Edvardsson Maria, Levander Märtha Sund, Ernerudh Jan, Theodorsson Elvar, Grodzinsky Ewa
Department of Medical and Health Sciences, Linköping University, Linköping, Sweden; Primary Health Care, Finspång, Sweden.
J Eval Clin Pract. 2015 Apr;21(2):229-35. doi: 10.1111/jep.12294. Epub 2014 Dec 11.
RATIONALE, AIMS AND OBJECTIVES: Reference intervals provided by the laboratory are commonly established by measuring samples from apparently healthy subjects in the ages 18-65 years, excluding elderly individuals with chronic diseases and medication. The aim of our study was to establish whether current reference intervals for immune parameters and chemical biomarkers are valid for older individuals including those with chronic diseases, so-called frail elderly.
Data from our cohort of 138 non-infected nursing home residents (NHR), mean age 86.8 years, range 80-98, were compared with raw data, as basis for the development of reference intervals, obtained from reference populations, like blood donors (IgA, IgG, IgM, C3 and C4) and from the Nordic Reference Interval Project (NORIP) (alanine aminotransferase, albumin, aspartate aminotransferase, creatinine, gamma-glutamyl transferase, lactate dehydrogenase, phosphate, sodium and urea). Immune parameters were measured by nephelometry and in NORIP the measurements were performed by means of different routine methods, in more than 100 laboratories.
Only nine individuals (7%) of NHR were found to be free from chronic disease. C3, C4 (P < 0.001) and IgG levels (P < 0.05) were higher, while IgM levels (P < 0.001) were lower in NHR compared with reference blood donors. Levels of alanine aminotransferase, phosphate (P < 0.001), albumin (P < 0.05) and sodium (P < 0.01) were lower while creatinine and urea levels were higher (P < 0.001) in NHR compared with NORIP subjects.
Comparing laboratory results from elderly people with conventional reference intervals can be misleading or even dangerous, as normal conditions may appear pathological, or vice versa and thus lead to unnecessary or even harmful treatment.
原理、目的和目标:实验室提供的参考区间通常是通过测量18至65岁明显健康受试者的样本确定的,不包括患有慢性病和正在服药的老年人。我们研究的目的是确定当前免疫参数和化学生物标志物的参考区间对包括患有慢性病的老年人(即所谓的体弱老年人)是否有效。
将我们138名未感染的养老院居民队列(NHR)的数据(平均年龄86.8岁,范围80 - 98岁)与作为参考区间制定基础的原始数据进行比较,这些原始数据来自参考人群,如献血者(IgA、IgG、IgM、C3和C4)以及北欧参考区间项目(NORIP)(丙氨酸转氨酶、白蛋白、天冬氨酸转氨酶、肌酐、γ-谷氨酰转移酶、乳酸脱氢酶、磷酸盐、钠和尿素)。免疫参数通过比浊法测量,在NORIP中,测量在100多个实验室通过不同的常规方法进行。
在NHR中仅发现9人(7%)无慢性病。与参考献血者相比,NHR中的C3、C4(P < 0.001)和IgG水平(P < 0.05)较高,而IgM水平(P < 0.001)较低。与NORIP受试者相比,NHR中的丙氨酸转氨酶、磷酸盐(P < 0.001)、白蛋白(P < 0.05)和钠水平(P < 0.01)较低,而肌酐和尿素水平较高(P < 0.001)。
将老年人的实验室结果与传统参考区间进行比较可能会产生误导甚至危险,因为正常情况可能看似病态,反之亦然,从而导致不必要甚至有害的治疗。